About ATHENAVAX
ABOUT US
At AthenaVax, we are dedicated to pioneering breakthrough solutions for breast, prostate, and brain cancer. Our mission is to help companies evaluate their products and lead the development of innovative therapeutic vaccines and small molecules designed to combat both primary and metastatic cancer. With a deep commitment to advancing oncology medicine, we strive to expand and enhance the lives of individuals battling cancer.
We believe in the power of collaboration and community as catalysts for medical innovation. By leveraging the latest scientific research and fostering partnerships with passionate problem- solvers, we are redefining the standards of cancer treatment development. Our approach centers on shared knowledge and a relentless pursuit of excellence, ensuring that we not only meet but exceed the expectations of our clients.
At AthenaVax, your challenges become our challenges. Together, we can transform discoveries into life-saving therapies. Join us in our mission to revolutionize cancer care and make a lasting impact on patients’ lives.
FOUNDED BY SCIENTISTS
The Driving Force Behind AthenaVax
AthenaVax was born from a deeply personal mission—transforming grief into groundbreaking innovation. Our founders have faced the heart-wrenching loss of loved ones to cancer, which ignited a passion to confront the challenges posed by this disease. This experience has instilled in us a profound commitment to (help) developing effective therapeutic vaccines and small molecules for breast, prostate, and brain cancer.
Understanding the urgency of viable treatment options, we strive to redefine the standards of oncology through collaboration and cutting-edge research. At AthenaVax, we are dedicated to providing hope and inspiring change, ensuring that no one has to face a future without possibilities.
We want to join you on your journey to turn tragedy into triumph. Together, we can create life-changing therapies and make a lasting impact on the lives of those battling cancer. Contact us today to explore how we can collaborate in advancing cancer treatment.
In loving memory of Penelope Koraka,
18 September 1973 – 2 May 2021
Whose strength and courage during her battle with breast cancer inspired my commitment to the global fight against cancer. Her suffering motivated me to contribute to innovative research for developing therapeutic vaccines and interventions, in the hope of creating a brighter future for others facing this disease.
Byron Martina | CEO & Founder AthenaVax
WHO WE SERVE
Early-stage Companies
Universities
Big Corporations
Research Institutes
Early-stage Companies
Universities
Research Institutes
Big Corporations
Every moment matters for oncology patients in need. Let us transform your discoveries into life-changing treatments – get started now!
Your partnership can make a difference. Contact us today to learn how we can collaborate in advancing cancer treatment.
Our Commitment to Your Success
Our success is defined by your achievements. We understand that transforming discoveries into effective medicine is an ambitious goal, and we are dedicated to providing tailored solutions while meticulously attending to every detail. Our agile and flexible approach allows us to adapt seamlessly to changing conditions throughout the development pathway.
Our partners expect technical excellence, responsive operations, and deep scientific expertise. To meet these high standards, we adhere to our Precision Principles, ensuring that AthenaVax is a nurturing environment where individuals are empowered, and teams can thrive.
We believe that by fostering collaboration and driving results every day, we can make a meaningful impact in the fight against cancer. Together, let’s transform innovative ideas into life-changing therapies.
OUR ADVISORY MEMBERS
Our Advisory Board is composed of experts in oncology, vaccine development, and biotechnology. Each member brings a wealth of knowledge and decades of experience, guiding our mission to develop innovative, epitope-based vaccines for brain, breast and prostate cancer. With their strategic insights, AthenaVax ensures the highest standards of scientific excellence and cutting-edge research. Our board’s expertise fuels our commitment to advancing cancer treatments and transforming the future of immunotherapy.
Dr Timothy Crook
Medical Oncologist
Prof. Musa M. Mhlanga
Cancer Cell Biologist
Prof. Andreas Tzako
Professor of Organic Chemistry-Chemical Biology